Treatment-resistant tinea caused by Trichophyton indotineae in Australia

Med J Aust. 2024 Aug 19;221(4):192-194. doi: 10.5694/mja2.52386. Epub 2024 Jul 16.

Authors

Kyra Yl Chua^{1

2}, Catriona L Halliday³, Sharon C-A Chen^{3

4}, Sonia Koning¹, Jedrzej Pawlikowski¹, Philipp du Cros¹, Tony M Korman^{1

5}

Affiliations

¹ Monash Health, Melbourne, VIC.
² University of Melbourne, and Peter Doherty Institute for Infection and Immunity, Melbourne, VIC.
³ Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, New South Wales Health Pathology, Westmead Hospital, Sydney, NSW.
⁴ University of Sydney, Sydney, NSW.
⁵ Monash University, Melbourne, VIC.

PMID: 39013435
DOI: 10.5694/mja2.52386

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antifungal Agents* / pharmacology
Antifungal Agents* / therapeutic use
Australia
Drug Resistance, Fungal
Humans
Male
Tinea* / diagnosis
Tinea* / drug therapy
Tinea* / microbiology
Trichophyton* / drug effects
Trichophyton* / isolation & purification

Substances

Antifungal Agents

Supplementary concepts

Trichophyton indotineae